Ampeak Energy Welcomes New Strategic Shareholder in Positive Step Forward, says Longspur Research 23 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video)
The Artisanal Spirits Company Sees Stabilisation and Growth Potential, Says Panmure Liberum 26 January 2026
Record Reports Strong Q3 Growth Driven by Net Flows and Asset Gains – Edison Investment Research 23 January 2026
Verici Dx landmark deal unlocks potential $300 million Tutivia market – Singer research ICYMI 22 January 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Challenges with Strategic Resilience 2 March 2026
PRUDENTIAL PLC ORD 5P (PRU.L) Stock Analysis: Unveiling a 19.99% Upside Potential for Investors 2 March 2026
UNITE GROUP PLC ORD 25P (UTG.L) Stock Report: Evaluating a 36.93% Potential Upside for Investors 2 March 2026
Ampeak Energy Welcomes New Strategic Shareholder in Positive Step Forward, says Longspur Research 23 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video)
The Artisanal Spirits Company Sees Stabilisation and Growth Potential, Says Panmure Liberum 26 January 2026
Record Reports Strong Q3 Growth Driven by Net Flows and Asset Gains – Edison Investment Research 23 January 2026
Verici Dx landmark deal unlocks potential $300 million Tutivia market – Singer research ICYMI 22 January 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Challenges with Strategic Resilience 2 March 2026
PRUDENTIAL PLC ORD 5P (PRU.L) Stock Analysis: Unveiling a 19.99% Upside Potential for Investors 2 March 2026
UNITE GROUP PLC ORD 25P (UTG.L) Stock Report: Evaluating a 36.93% Potential Upside for Investors 2 March 2026
Centessa Pharmaceuticals (CNTA) Stock Analysis: 30% Upside Potential Amid Robust Buy Ratings 2 December 2025
SS Innovations International (SSII) Stock Analysis: A Healthcare Pioneer with Astonishing 192.5% Revenue Growth 2 December 2025
Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating a 8.43% Potential Upside Amidst Market Challenges 2 December 2025
Artivion, Inc. (AORT) Stock Analysis: Investor Insight into a 12.84% Potential Upside in the Medical Devices Sector 2 December 2025
Premier, Inc. (PINC) Stock Analysis: Navigating Health Information Services with a 2.97% Dividend Yield 2 December 2025
Surgery Partners, Inc. (SGRY) Investor Outlook: Targeting a 50% Upside with Strong Analyst Support 2 December 2025
UFP Technologies, Inc. (UFPT) Stock Analysis: Unveiling a 48.72% Potential Upside for Investors 2 December 2025
Adaptive Biotechnologies Corp (ADPT): Investor Outlook with 102.4% Revenue Growth and Strategic Collaborations 2 December 2025
Alphatec Holdings, Inc. (ATEC) Stock Analysis: Strong Revenue Growth and Analyst Confidence Highlight Investment Potential 2 December 2025
Edgewise Therapeutics (EWTX) Stock Analysis: Exploring a 51% Potential Upside in the Biotech Sector 2 December 2025
Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A High-Stakes Play in Biotech with 5.90% Potential Upside 2 December 2025
Clover Health Investments, Corp (CLOV): Growth Potential and Analyst Outlook for Healthcare Investors 2 December 2025
Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Challenges with Growth Potential in Healthcare 2 December 2025
ImmunityBio, Inc. (IBRX) Stock Analysis: Exploring a Biotech Gem with a 343% Potential Upside 2 December 2025
Phreesia, Inc. (PHR) Stock Analysis: Unveiling a 67.73% Potential Upside in Health Information Services 2 December 2025
MoonLake Immunotherapeutics (MLTX): Exploring Growth Potential in the Biotech Sector with a 10% Upside 2 December 2025
Indivior PLC (INDV) Stock Analysis: Navigating a 9.27% Potential Upside with Strategic Growth in Opioid Treatment 2 December 2025
Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A Biotech with a 146.70% Revenue Growth Surge and Promising Buy Ratings 2 December 2025
Ascentage Pharma Group International (AAPG): Investor Outlook Reveals 38.89% Potential Upside in the Biotechnology Sector 2 December 2025
Immunocore Holdings plc (IMCR) Stock Analysis: Exploring a Potential 69.97% Upside in the Biotech Sector 2 December 2025
NB Private Equity Returns Stay Strong as Exit Pipeline Builds and Buybacks Accelerate (Video) 19 December 2025
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video) 17 December 2025
Peter Cruddas CEO CMC Markets: Building a Fintech Powerhouse from London to Sydney (Video) 11 December 2025
The Artisanal Spirits Company Sees Stabilisation and Growth Potential, Says Panmure Liberum 26 January 2026
Record Reports Strong Q3 Growth Driven by Net Flows and Asset Gains – Edison Investment Research 23 January 2026
Verici Dx landmark deal unlocks potential $300 million Tutivia market – Singer research ICYMI 22 January 2026
Ampeak Energy Welcomes New Strategic Shareholder in Positive Step Forward, says Longspur Research 23 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Challenges with Strategic Resilience 2 March 2026
PRUDENTIAL PLC ORD 5P (PRU.L) Stock Analysis: Unveiling a 19.99% Upside Potential for Investors 2 March 2026
UNITE GROUP PLC ORD 25P (UTG.L) Stock Report: Evaluating a 36.93% Potential Upside for Investors 2 March 2026
